
Efficacy & Safety of Niraparib Similar for Ovarian Cancer Patients Regardless of Age
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000723516.72871.fd
Subject(s) - medicine , ovarian cancer , placebo , oncology , randomized controlled trial , post hoc analysis , subgroup analysis , stage (stratigraphy) , cancer , clinical trial , progression free survival , disease , quality of life (healthcare) , gynecology , overall survival , alternative medicine , meta analysis , pathology , paleontology , biology , nursing